Sfoglia per Autore

opzioni
Mostrati risultati da 1 a 20 di 70
Titolo Data di pubblicazione Autore(i) File
New oral drugs for multiple sclerosis 1-gen-2009 Gasperini, Claudio; Ruggieri, Serena
Emerging oral treatments in multiple sclerosis - clinical utility of cladribine tablets 1-gen-2010 Pozzilli, Carlo; Gasperini, Claudio; Ruggieri, Serena
Emerging oral drugs for relapsingremitting multiple sclerosis 1-gen-2011 Gasperini, Claudio; Ruggieri, Serena
Development of oral agent in the treatment of multiple sclerosis: How the first available oral therapy, fingolimod will change therapeutic paradigm approach 1-gen-2012 Gasperini, Claudio; Ruggieri, Serena
Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis 1-gen-2013 Daniela F., Angelini; Barbara, Serafini; Eleonora, Piras; Martina, Severa; Eliana M., Coccia; Barbara, Rosicarelli; Fabio, Buttari; Diego, Centonze; Mechelli, Rosella; Salvetti, Marco; Giovanna, Borsellino; Francesca, Aloisi; Luca, Battistini; Ruggieri, Serena; Gasperini, Claudio
Advances in the treatment of relapsing-remitting multiple sclerosis - critical appraisal of fingolimod. Ther Clin Risk Manag. 2013;9:73-85. doi: 10.2147/TCRM.S17426. Epub 2013 Mar 3. 1-gen-2013 Gasperini, Claudio; Ruggieri, S; Mancinelli, Cr; Pozzilli, Carlo
CD28 individual signals amplify pro-inflammatory cytokine production in relapse-remitting multiple sclerosis T lymphocytes. 1-gen-2013 Loretta, Tuosto; Muscolini, Michela; Camperio, Cristina; Elisabetta, Volpe; Mechelli, Rosella; Ruggieri, Serena; Salvetti, Marco; Gasperini, Claudio; Luca, Battistini
Drugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies 1-gen-2013 Gasperini, Claudio; Haggiag, Shalom; Ruggieri, Serena
Efficacy and safety of laquinimod in multiple sclerosis: Current status 1-gen-2013 Haggiag, Shalom; Ruggieri, Serena; Gasperini, Claudio
Advances in the treatment of relapsing-remitting multiple sclerosis - Critical appraisal of fingolimod 1-gen-2013 Gasperini, Claudio; Ruggieri, Serena; Mancinelli, Chiara Rosa; Pozzilli, Carlo
CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes. 1-gen-2014 Camperio, Cristina; Muscolini, Michela; E., Volpe; D., Di Mitri; Mechelli, Rosella; Buscarinu, Maria Chiara; Ruggieri, Serena; Piccolella, Enza; Salvetti, Marco; Gasperini, Claudio; L., Battistini; Tuosto, Loretta
Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing-remitting multiple sclerosis 1-gen-2014 Ruggieri, Serena; Tortorella, Carla; Gasperini, Claudio
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy 1-gen-2014 Totaro, R; Lugaresi, A; Bellantonio, P; Danni, M; Costantino, G; Gasperini, Claudio; Florio, C; Pucci, E; Maddestra, M; Spitaleri, D; Lus, G; Ardito, B; Farina, D; Rossi, M; Di Carmine, C; Altobelli, E; Maccarone, B; Casalena, A; De Luca, G; Travaglini, D; Di Ioia, M; Di Tommaso, V; Fantozzi, R; Ruggieri, Serena; Provinciali, L; De Riso, S; Mundi, C; Fuiani, A; Galgani, S; Ruggieri, S; Maniscalco, G. T; Giuliani, G; Cartechini, E; Petretta, V; Fratta, M; Alfieri, G; Gatto, M; Carolei, A.
Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration 1-gen-2014 Kearney, H; Rocca, M. A.; Valsasina, P.; Balk, L.; Sastre Garriga, J.; Reinhardt, J.; Ruggieri, Serena; Rovira, A.; Stippich, C.; Kappos, L.; Sprenger, T.; Tortorella, P.; Rovaris, M.; Gasperini, Claudio; Montalban, X.; Geurts, J. J. G.; Polman, C. H.; Barkhof, F.; Filippi, M.; Altmann, D. R.; Ciccarelli, O.; Miller, D. H.; Chard, D. T.
Association of deep gray matter damage with cortical and spinal cord degeneration in primary progressive multiple sclerosis 1-gen-2015 Ruggieri, Serena; Petracca, Maria; Miller, Aaron; Krieger, Stephen; Ghassemi, Rezwan; Bencosme, Yadira; Riley, Claire; Howard, Jonathan; Lublin, Fred; Inglese, Matilde
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis 1-gen-2015 Ruocco, Gabriella; Rossi, Silvia; Motta, Caterina; Macchiarulo, Giulia; Barbieri, Francesca; De Bardi, Marco; Borsellino, Giovanna; Finardi, Annamaria; Grasso, Maria Grazia; Ruggieri, Serena; Gasperini, Claudio; Furlan, Roberto; Centonze, Diego; Battistini, Luca; Volpe, Elisabetta
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients 1-gen-2015 Cencioni, M. T; Santini, S; Ruocco, G; Borsellino, G; De Bardi, M; Grasso, M. G; Ruggieri, S; Gasperini, Claudio; Centonze, D; Barilá, D; Battistini, L; Volpe, E.
Dysregulated homeostasis of acetylcholine levels in immune cells of RR-multiple sclerosis patients 1-gen-2016 DI BARI, Maria; Reale, Marcella; Di Nicola, Marta; Orlando, Viviana; Galizia, Sabrina; Porfilio, Italo; Costantini, Erica; D’Angelo, Chiara; Ruggieri, Serena; Biagioni, Stefano; Gasperini, Claudio; Tata, Ada Maria
Anti lingo 1 (opicinumab) a new monoclonal antibody tested in relapsing remitting multiple sclerosis 1-gen-2017 Ruggieri, Serena; Tortorella, Carla; Gasperini, Claudio
Modulation of P2X7 receptor during inflammation in multiple sclerosis 1-gen-2017 Amadio, Susanna; Parisi, Chiara; Piras, Eleonora; Fabbrizio, Paola; Apolloni, Savina; Montilli, Cinzia; Luchetti, Sabina; Ruggieri, Serena; Gasperini, Claudio; Laghi-Pasini, Franco; Battistini, Luca; Volonté, Cinzia
Mostrati risultati da 1 a 20 di 70
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile